ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,283Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 273

$651K Total Retail Price of All Prescriptions

Rank: 34 out of 273

1,502 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

1% of this provider’s 1,502 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 9,743 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

8 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
METOPROLOL SUCCINATE 654 575 1 1
METOPROLOL TARTRATE 617 534 2 10
LISINOPRIL 603 510 3 4
ATORVASTATIN CALCIUM 569 475 4 8
FUROSEMIDE 536 453 5 5
AMLODIPINE BESYLATE 511 446 6 2
WARFARIN SODIUM 469 446 7 7
CARVEDILOL 456 411 8 3
SIMVASTATIN 405 355 9 6
NITROSTAT 343 271 10 28
CRESTOR 308 273 11 14
PRAVASTATIN SODIUM 298 269 12 11
POTASSIUM CHLORIDE 285 237 13 18
HYDROCHLOROTHIAZIDE 275 257 14 16
CLOPIDOGREL 272 222 15 9
PLAVIX 189 159 16 12
ISOSORBIDE MONONITRATE ER 184 156 17 13
DIOVAN 173 148 18 21
HYDRALAZINE HCL 164 145 19 36
LOSARTAN POTASSIUM 158 143 20 19
ATENOLOL 157 135 21 17
SPIRONOLACTONE 145 116 22 20
PRADAXA 140 133 23 22
DIGOXIN 113 106 24 15
ENALAPRIL MALEATE 109 98 25 31
RAMIPRIL 105 97 26 24
COUMADIN 97 94 27 50
CLONIDINE HCL 87 77 28 32
NIASPAN 81 74 29 51
AMIODARONE HCL 80 63 30 23
LOVAZA 79 66 31 60
LIPITOR 76 74 32 29
FENOFIBRATE 75 60 33 34
QUINAPRIL HCL 71 66 34 76
MULTAQ 70 70 35 52
FOSINOPRIL SODIUM 69 69 36 112
BENAZEPRIL HCL 67 55 37 35
METOLAZONE 66 58 38 94
ISOSORBIDE DINITRATE 62 53 39 74
BYSTOLIC 61 56 40 26
TRIAMTERENE-HCTZ 59 59 41 53
PANTOPRAZOLE SODIUM 56 43 42 41
BUMETANIDE 56 51 42 54
LEVOTHYROXINE SODIUM 54 39 44 25
OMEPRAZOLE 53 50 45 33
LOVASTATIN 50 42 46 44
ZETIA 50 39 46 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.